DiaSys Corporation Share Price

Equities

DYXC

US2528381070

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 15:28:52 25/04/2024 BST 5-day change 1st Jan Change
0.00002 USD -90.00% Intraday chart for DiaSys Corporation -.--% -98.00%
Sales 2006 1.69M 134M Sales 2007 1.68M 133M Capitalization 2.83M 224M
Net income 2006 -1M -79.1M Net income 2007 - 0 EV / Sales 2006 2.7 x
Net Debt 2006 302K 23.89M Net Debt 2007 594K 47.01M EV / Sales 2007 2.04 x
P/E ratio 2006
-3.78 x
P/E ratio 2007
-3 x
Employees -
Yield 2006 *
-
Yield 2007
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Current year
0.00
Extreme 0
0.00
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.00
5 years
0.00
Extreme 0
0.00
10 years
0.00
Extreme 0
0.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
More insiders
DiaSys Corporation (DiaSys) designs, develops, manufactures and distributes workstation-instruments, consumables, reagents and specialized test kits to hospital, clinical and private physician laboratories globally. The Company’s workstation instruments standardize laboratory analysis of urine sediment, fecal concentrates, cerebral spinal fluid (CSF), fine needle aspirations (FNA) and other cell suspensions. The Company’s wholly owned subsidiary, DiaSys Europe Limited markets the Company’s urinalysis and parasitology workstations, the full DiaSys line of rapid test kits, consumables, immunology, oncology and virology products and manufactures reagents. The two product categories of the Company are workstation-systems, and disposable consumables, diagnostic test products and kits. DiaSys sells its products in North America both directly and through strategic distribution relationships with Cardinal Heath and Fisher Healthcare.
More about the company